Complete Filing Data
MAXCYTE, INC. reported Stockholders Equity of $171.49 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean MAXCYTE, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$44.6M | -$41.1M | -$37.9M | -$23.6M | -$19.1M | -$11.8M | -$12.9M |
| Cost of Revenue * | $6.2M | $7.1M | $4.7M | $5.1M | $3.6M | $2.8M | $2.5M |
| Selling And Marketing Expense | $18.9M | $26.7M | $27.0M | $18.7M | $13.0M | $8.3M | $7.9M |
| Revenues | $33.0M | $38.6M | $41.3M | $44.3M | $33.9M | $26.2M | $21.6M |
| Research And Development Expense | $20.8M | $22.2M | $23.8M | $19.5M | $15.4M | $17.7M | $17.6M |
| Other Nonoperating Income Expense | $7.3M | $10.1M | $10.4M | $3.8M | -$893.6K | -$759.7K | -$475.0K |
| Operating Income Loss | -$51.9M | -$51.2M | -$48.3M | -$27.4M | -$18.2M | -$11.1M | -$12.4M |
| Operating Expenses | $78.7M | $82.7M | $84.8M | $66.5M | $48.4M | $34.5M | $31.5M |
| Gross Profit | $26.8M | $31.5M | $36.5M | $39.2M | $30.2M | $23.4M | $19.1M |
| General And Administrative Expense | $28.1M | $29.7M | $30.1M | $25.8M | $18.7M | $7.4M | $5.6M |
| Deferred Revenue Current | $3.6M | $5.3M | $5.1M | $6.7M | $6.7M | $4.8M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$44.6M | -$41.1M | -$37.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$12.4M | -$12.4M | -$10.3M | -$11.6M | -$9.4M | -$9.5M | -$11.3M | -$10.5M | -$10.9M | -$6.4M | -$8.3M | -$4.1M | -$2.7M | -$4.4M | -$7.1M | -$3.1M | -$3.0M | -$3.1M |
| Cost of Revenue * | $1.6M | $1.5M | $1.5M | $1.9M | $1.5M | $1.4M | $793.0K | $1.4M | $1.0M | $1.4M | $1.1M | $1.1M | $943.8K | $784.5K | $693.1K | $734.8K | $466.3K | |
| Selling And Marketing Expense | $3.9M | $5.8M | $5.7M | $6.2M | $6.6M | $7.4M | $7.0M | $6.4M | $6.3M | $4.5M | $4.9M | $3.8M | $3.2M | $2.9M | $2.8M | $2.0M | $1.8M | |
| Revenues | $6.8M | $8.5M | $10.4M | $8.2M | $10.4M | $11.3M | $8.0M | $9.0M | $8.6M | $10.6M | $9.6M | $11.6M | $10.1M | $7.1M | $6.5M | $6.8M | $5.2M | |
| Research And Development Expense | $5.3M | $6.3M | $5.9M | $5.3M | $5.6M | $6.7M | $6.3M | $5.7M | $6.0M | $5.3M | $4.7M | $3.8M | $2.7M | $3.2M | $6.1M | $4.5M | $4.1M | |
| Other Nonoperating Income Expense | $1.7M | $1.9M | $2.0M | $2.5M | $2.6M | $2.7M | $2.7M | $2.6M | $2.3M | $1.3M | $478.7K | $91.8K | -$237.5K | -$4.6K | -$732.5K | -$256.4K | -$159.5K | |
| Operating Income Loss | -$14.1M | -$14.2M | -$12.3M | -$14.1M | -$12.0M | -$12.3M | -$14.0M | -$13.1M | -$13.2M | -$7.7M | -$8.7M | -$4.2M | -$2.4M | -$4.4M | -$6.4M | -$2.8M | -$2.8M | |
| Operating Expenses | $19.4M | $21.2M | $21.2M | $20.3M | $20.9M | $22.2M | $21.2M | $20.7M | $20.8M | $17.0M | $17.2M | $14.7M | $11.6M | $10.7M | $12.2M | $8.9M | $7.5M | |
| Gross Profit | $5.2M | $7.0M | $8.9M | $6.2M | $8.9M | $9.9M | $7.2M | $7.7M | $7.6M | $9.3M | $8.5M | $10.5M | $9.2M | $6.3M | $5.8M | $6.0M | $4.7M | |
| General And Administrative Expense | $6.0M | $8.1M | $8.5M | $7.7M | $7.6M | $7.1M | $6.8M | $7.7M | $7.5M | $6.4M | $7.1M | $6.6M | $5.3M | $4.3M | $3.0M | $2.3M | $1.6M | |
| Deferred Revenue Current | $5.2M | $2.6M | $4.1M | $6.7M | $3.4M | $4.5M | $5.6M | $4.7M | $5.7M | $6.3M | $7.3M | $6.8M | $6.3M | $6.8M | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$12.4M | -$12.4M | -$10.3M | -$11.6M | -$9.4M | -$9.5M | -$11.3M | -$10.5M | -$10.9M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $171.5M | $206.3M | $232.2M | $254.0M | $262.9M | $33.2M | $13.6M | $12.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $20.1M | $27.9M | $46.5M | $11.1M | $47.8M | $18.8M | $15.2M | $11.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$7.8M | -$18.6M | $35.4M | -$36.7M | $29.0M | $3.5M | $4.0M | |
| Accretion Amortization Of Discounts And Premiums Investments | $2.6M | $6.2M | $7.1M | $2.7M | $70.3K | $3.8K | $32.6K | |
| Short Term Investments | $83.0M | $126.6M | $121.8M | $216.3M | $207.3M | $16.0M | ||
| Retained Earnings Accumulated Deficit | -$261.5M | -$216.9M | -$175.8M | -$137.9M | -$114.3M | -$95.2M | ||
| Property Plant And Equipment Net | $17.5M | $19.7M | $23.5M | $23.7M | $7.7M | $4.5M | ||
| Other Assets Noncurrent | $2.5M | $1.5M | $388.0K | $809.0K | $316.7K | $33.9K | ||
| Operating Lease Right Of Use Asset | $10.9M | $10.8M | $11.2M | $9.9M | $5.7M | $1.7M | ||
| Operating Lease Liability Noncurrent | $16.5M | $17.2M | $18.0M | $15.9M | $5.2M | $1.2M | ||
| Operating Lease Liability Current | $1.5M | $864.0K | $774.0K | $157.0K | $527.2K | $572.6K | ||
| Liabilities Current | $14.3M | $15.8M | $17.9M | $15.4M | $15.6M | $11.6M | ||
| Liabilities And Stockholders Equity | $202.5M | $239.5M | $268.3M | $286.7M | $284.1M | $51.8M | ||
| Liabilities | $31.0M | $33.2M | $36.1M | $32.7M | $21.2M | $18.6M | ||
| Inventory Net | $7.5M | $8.9M | $12.2M | $8.6M | $5.2M | $4.3M | ||
| Common Stock Value | $1.1M | $1.1M | $1.0M | $1.0M | $1.0M | $773.8K | ||
| Cash And Cash Equivalents At Carrying Value | $20.1M | $27.9M | $46.5M | $11.1M | $47.8M | $18.8M | ||
| Assets Current | $118.4M | $171.7M | $190.2M | $252.3M | $270.4M | $45.3M | ||
| Assets | $202.5M | $239.5M | $268.3M | $286.7M | $284.1M | $51.8M | ||
| Accrued Liabilities And Other Liabilities | $7.8M | $8.3M | $11.3M | $8.3M | $6.5M | $5.3M | ||
| Accounts Receivable Net Current | $3.5M | $4.7M | $5.8M | $11.2M | $6.9M | $5.2M | ||
| Accounts Payable Current | $1.4M | $1.4M | $743.0K | $292.0K | $1.8M | $890.2K | ||
| Other Liabilities Noncurrent | $263.0K | $274.0K | $283.0K | $1.3M | $450.2K | $788.8K | ||
| Prepaid Expense And Other Assets Current | $4.3M | $3.6M | $3.9M | $3.3M | $3.3M | $1.0M | ||
| Gain Loss On Sale Of Property Plant Equipment | -$287.0K | -$861.0K | -$30.0K | -$139.0K | -$32.5K | -$25.9K | -$1.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $180.3M | $190.7M | $199.4M | $213.3M | $221.3M | $226.4M | $233.4M | $241.0M | $247.8M | $254.4M | $257.2M | $262.2M | $264.1M | $78.8M | $81.3M | $35.0M | $37.2M | $11.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $13.0M | $15.2M | $23.4M | $37.0M | $37.5M | $22.2M | $49.2M | $54.6M | $37.8M | $43.0M | $109.2M | $239.8M | $59.0M | $37.4M | $78.7M | $21.0M | $38.2M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$4.5M | -$24.3M | $26.8M | $192.0M | $59.9M | |||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $884.0K | $2.0M | $1.7M | $33.2K | -$7.5K | |||||||||||||
| Short Term Investments | $92.8M | $111.3M | $114.9M | $116.9M | $119.8M | $135.3M | $141.1M | $161.6M | $186.8M | $189.9M | $131.7M | $6.5M | $196.9M | $36.0M | ||||
| Retained Earnings Accumulated Deficit | -$251.9M | -$239.5M | -$227.1M | -$206.3M | -$194.7M | -$185.3M | -$170.5M | -$159.3M | -$148.8M | -$133.1M | -$126.6M | -$118.4M | -$109.4M | -$106.7M | ||||
| Property Plant And Equipment Net | $18.6M | $19.4M | $19.9M | $21.0M | $21.7M | $22.8M | $23.8M | $24.3M | $24.9M | $23.0M | $20.6M | $13.2M | $6.8M | $5.5M | ||||
| Other Assets Noncurrent | $2.6M | $2.8M | $1.9M | $1.1M | $640.0K | $295.0K | $619.4K | $597.3K | $399.3K | $1.2M | $920.5K | $1.1M | $318.1K | $1.7M | ||||
| Operating Lease Right Of Use Asset | $11.1M | $11.3M | $11.5M | $10.9M | $11.0M | $11.1M | $9.6M | $9.7M | $9.8M | $10.0M | $10.4M | $10.9M | $1.0M | $1.2M | ||||
| Operating Lease Liability Noncurrent | $16.8M | $17.2M | $17.5M | $17.4M | $17.7M | $17.8M | $15.4M | $15.7M | $15.8M | $14.9M | $14.1M | $12.8M | $500.2K | $606.7K | ||||
| Operating Lease Liability Current | $1.3M | $1.3M | $1.3M | $907.0K | $878.0K | $825.0K | $698.7K | $498.6K | $475.2K | $152.2K | $438.7K | $480.2K | $572.3K | $616.5K | ||||
| Liabilities Current | $16.1M | $11.6M | $12.7M | $17.6M | $12.3M | $13.5M | $16.6M | $13.2M | $16.6M | $16.8M | $18.1M | $15.5M | $12.6M | $12.5M | ||||
| Liabilities And Stockholders Equity | $213.5M | $219.8M | $230.0M | $248.6M | $251.5M | $257.9M | $266.7M | $271.2M | $281.5M | $286.4M | $289.8M | $291.0M | $277.7M | $93.1M | ||||
| Liabilities | $33.2M | $29.0M | $30.5M | $35.3M | $30.2M | $31.6M | $33.4M | $30.2M | $33.7M | $32.0M | $32.6M | $28.8M | $13.6M | $14.3M | ||||
| Inventory Net | $7.6M | $7.9M | $8.3M | $10.4M | $11.2M | $12.0M | $12.5M | $11.0M | $10.3M | $7.9M | $7.7M | $6.6M | $4.1M | $4.2M | ||||
| Common Stock Value | $1.1M | $1.1M | $1.1M | $1.1M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $847.2K | ||||
| Cash And Cash Equivalents At Carrying Value | $13.0M | $15.2M | $23.4M | $37.0M | $37.5M | $22.2M | $49.2M | $54.6M | $37.8M | $43.0M | $109.2M | $239.8M | $59.0M | $37.4M | ||||
| Assets Current | $124.6M | $143.2M | $155.7M | $172.9M | $175.6M | $178.7M | $214.3M | $236.6M | $246.4M | $252.3M | $257.8M | $265.8M | $269.5M | $84.6M | ||||
| Assets | $213.5M | $219.8M | $230.0M | $248.6M | $251.5M | $257.9M | $266.7M | $271.2M | $281.5M | $286.4M | $289.8M | $291.0M | $277.7M | $93.1M | ||||
| Accrued Liabilities And Other Liabilities | $8.3M | $6.4M | $5.0M | $8.2M | $7.1M | $6.5M | $9.9M | $6.4M | $6.9M | $8.2M | $7.9M | $3.9M | $5.0M | $4.5M | ||||
| Accounts Receivable Net Current | $8.3M | $5.8M | $5.5M | $4.6M | $4.6M | $6.0M | $8.2M | $7.6M | $8.3M | $7.4M | $7.4M | $8.6M | $6.0M | $5.7M | ||||
| Accounts Payable Current | $1.3M | $1.2M | $2.3M | $1.9M | $953.0K | $1.7M | $446.6K | $1.6M | $3.5M | $2.1M | $2.5M | $4.4M | $723.3K | $644.7K | ||||
| Other Liabilities Noncurrent | $227.0K | $248.0K | $270.0K | $277.0K | $310.0K | $279.0K | $1.3M | $1.3M | $1.3M | $393.0K | $451.1K | $496.6K | $1.2M | |||||
| Prepaid Expense And Other Assets Current | $3.0M | $3.0M | $3.7M | $4.1M | $2.6M | $3.2M | $3.4M | $1.9M | $2.2M | $3.3M | $1.3M | $2.2M | ||||||
| Gain Loss On Sale Of Property Plant Equipment | -$47.0K | -$6.1K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $4.3M | $4.3M | $4.2M | $2.7M | $1.4M | $1.0M | $613.5K |
| Share Based Compensation | $9.2M | $13.1M | $14.0M | $11.8M | $8.0M | $2.5M | $1.8M |
| Payments To Acquire Property Plant And Equipment | $1.8M | $1.7M | $3.7M | $18.5M | $3.8M | $2.1M | $1.3M |
| Net Cash Provided By Used In Operating Activities | -$34.4M | -$27.6M | -$21.7M | -$14.8M | -$10.7M | -$8.8M | -$8.8M |
| Net Cash Provided By Used In Investing Activities | $25.9M | $6.9M | $55.0M | -$24.8M | -$195.0M | -$16.6M | $454.5K |
| Net Cash Provided By Used In Financing Activities | $656.0K | $2.1M | $2.1M | $2.9M | $234.7M | $28.9M | $12.3M |
| Increase Decrease In Other Operating Liabilities | -$36.0K | -$9.0K | -$39.0K | $871.0K | -$73.5K | -$58.0K | -$655.0K |
| Increase Decrease In Operating Lease Liability | -$1.2M | -$709.0K | -$133.0K | $5.5M | $3.9M | -$508.8K | $68.6K |
| Increase Decrease In Inventories | -$575.0K | -$1.4M | $4.5M | $3.5M | $1.4M | $890.6K | $1.9M |
| Increase Decrease In Deferred Revenue | -$1.7M | $182.0K | -$1.6M | -$34.0K | $1.9M | $1.6M | $795.9K |
| Increase Decrease In Accounts Receivable | -$1.1M | -$1.2M | -$5.2M | $4.6M | $1.7M | $1.8M | -$1.6M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$3.7M | -$1.9M | $3.3M | -$150.0K | $2.1M | $391.0K | $1.2M |
| Proceeds From Stock Options Exercised | $432.0K | $1.6M | $1.9M | $2.9M | $3.6M | $401.0K | $132.7K |
| Increase Decrease In Other Noncurrent Assets | $724.0K | $1.2M | -$421.0K | $492.0K | $282.8K | $33.9K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $531.0K | -$293.0K | $641.0K | -$320.0K | $2.3M | ||
| Proceeds From Issuance Of Common Stock | $51.8M | $28.6M | $12.3M | ||||
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $313.8M | $284.6M | $77.5M | $8.0M | $9.1M | ||
| Increase Decrease In Right Of Use Asset Operating Leases | $4.2M | $3.8M | -$525.0K | -$474.6K | |||
| Proceeds From Sale Maturity And Collections Of Investments | $155.8M | $159.4M | $313.8M | ||||
| Payments To Acquire Short Term Investments | $255.1M | $290.9M | $268.7M | $22.5M | $7.4M | ||
| Payments To Acquire Investments | $126.3M | $150.9M | $255.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.0M | $962.0K | $743.3K | $547.4K | $487.4K | $366.0K | $325.0K | $315.9K |
| Share Based Compensation | $3.0M | $3.0M | $3.3M | $2.5M | $1.3M | ||||||||
| Payments To Acquire Property Plant And Equipment | $653.0K | $804.0K | $1.6M | $6.0M | $308.5K | ||||||||
| Net Cash Provided By Used In Operating Activities | -$14.4M | -$10.6M | -$4.3M | -$3.7M | -$4.6M | ||||||||
| Net Cash Provided By Used In Investing Activities | $9.5M | -$14.4M | $29.6M | $194.8M | $15.7M | ||||||||
| Net Cash Provided By Used In Financing Activities | $383.0K | $703.0K | $1.5M | $892.6K | $48.9M | ||||||||
| Increase Decrease In Other Operating Liabilities | -$4.0K | -$4.0K | -$13.0K | $900.00 | $73.4K | ||||||||
| Increase Decrease In Operating Lease Liability | -$278.0K | -$103.0K | $157.0K | $7.6M | -$137.6K | ||||||||
| Increase Decrease In Inventories | -$531.0K | -$169.0K | $1.7M | $1.4M | $287.9K | ||||||||
| Increase Decrease In Deferred Revenue | -$1.3M | -$593.0K | -$963.0K | $84.9K | $1.2M | ||||||||
| Increase Decrease In Accounts Receivable | $839.0K | $343.0K | -$3.4M | $1.8M | -$877.6K | ||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$5.6M | -$3.3M | $1.2M | -$150.5K | -$1.4M | ||||||||
| Proceeds From Stock Options Exercised | $383.0K | $703.0K | $1.5M | $892.6K | $2.0M | ||||||||
| Increase Decrease In Other Noncurrent Assets | $254.0K | -$33.0K | -$410.0K | $738.2K | $49.1K | ||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$65.0K | -$689.0K | -$509.0K | -$1.1M | |||||||||
| Proceeds From Issuance Of Common Stock | $51.8M | ||||||||||||
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $89.0M | $200.8M | $16.0M | ||||||||||
| Increase Decrease In Right Of Use Asset Operating Leases | -$95.9K | $5.2M | -$137.3K | ||||||||||
| Proceeds From Sale Maturity And Collections Of Investments | $46.6M | $34.5M | $89.0M | ||||||||||
| Payments To Acquire Short Term Investments | $57.8M | ||||||||||||
| Payments To Acquire Investments | $34.6M | $48.0M | $57.8M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 106.4M | 104.8M | 103.3M | 101.7M | 90.6M | 69.5M | 56.4M |
| Earnings Per Share Basic | $-0.42 | $-0.39 | $-0.37 | $-0.23 | $-0.21 | $-0.17 | $-0.23 |
| Weighted Average Number Of Diluted Shares Outstanding | 106.4M | 104.8M | 103.3M | 101.7M | 90.6M | 69.5M | 56.4M |
| Earnings Per Share Diluted | $-0.42 | $-0.39 | $-0.37 | $-0.23 | $-0.21 | $-0.17 | $-0.23 |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |
| Common Stock Shares Outstanding | 106.8M | 105.7M | 104.0M | 102.4M | 101.2M | 77.4M | |
| Common Stock Shares Issued | 106.8M | 105.7M | 104.0M | 102.4M | 101.2M | 77.4M | |
| Common Stock Shares Authorized | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 200.0M | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 106.6M | 106.4M | 106.0M | 105.1M | 104.6M | 104.1M | 103.4M | 103.1M | 102.8M | 101.8M | 101.4M | 101.3M | 95.7M | 84.7M | 81.0M | 77.1M | 65.8M |
| Earnings Per Share Basic | $-0.12 | $-0.12 | $-0.10 | $-0.11 | $-0.09 | $-0.09 | $-0.11 | $-0.10 | $-0.11 | $-0.06 | $-0.08 | $-0.04 | $-0.03 | $-0.05 | $-0.09 | $-0.04 | $-0.05 |
| Weighted Average Number Of Diluted Shares Outstanding | 106.6M | 106.4M | 106.0M | 105.1M | 104.6M | 104.1M | 103.4M | 103.1M | 102.8M | 101.8M | 101.4M | 101.3M | 84.7M | 84.7M | 81.0M | 77.1M | 65.8M |
| Earnings Per Share Diluted | $-0.12 | $-0.12 | $-0.11 | $-0.09 | $-0.11 | $-0.10 | $-0.11 | $-0.06 | $-0.08 | $-0.04 | $-0.03 | $-0.05 | $-0.09 | $-0.04 | $-0.05 | ||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||||
| Common Stock Shares Outstanding | 106.6M | 106.6M | 106.3M | 105.3M | 104.8M | 104.4M | 103.5M | 103.1M | 102.9M | 101.9M | 101.7M | 101.5M | 100.4M | 84.7M | |||
| Common Stock Shares Issued | 106.6M | 106.6M | 106.3M | 105.3M | 104.8M | 104.4M | 103.5M | 103.1M | 102.9M | 101.9M | 101.7M | 101.5M | 100.4M | 84.7M | |||
| Common Stock Shares Authorized | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 200.0M | 200.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $9.2M | $13.1M | $14.0M | $11.8M | $8.0M | $2.5M | $1.8M |
| Stock Issued During Period Value Stock Options Exercised | $432.0K | $1.6M | $1.9M | $2.9M | $3.6M | $401.0K | $132.7K |
| Investment Income Interest | $7.3M | $10.1M | $10.4M | $3.9M | $150.8K | $65.9K | $206.1K |
| Depreciation And Amortization | $4.2M | $4.1M | $4.0M | $2.5M | $1.3M | $1.0M | $541.3K |
| Net Book Value Of Consigned Equipment Sold | $83.0K | $63.0K | $94.0K | $76.0K | $51.6K | $79.9K | $25.0K |
| Additional Paid In Capital | $431.9M | $422.0M | $406.9M | $390.8M | $376.2M | $127.7M | |
| Capital Expenditures Incurred But Not Yet Paid | $33.0K | $97.0K | $566.0K | $363.0K | $296.4K | $70.9K | $399.9K |
| Interest And Other Expense | $127.0K | $1.0M | $825.6K | $681.1K | |||
| Provision For Doubtful Accounts | $35.0K | -$130.0K | $171.0K | -$117.2K | $54.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.0M | $3.5M | $3.0M | $3.4M | $3.6M | $3.0M | $3.6M | $3.5M | $3.3M | $3.2M | $3.0M | $2.5M | $2.3M | $1.9M | $1.3M | $598.0K | $559.0K | $547.6K |
| Stock Issued During Period Value Stock Options Exercised | $14.0K | $20.0K | $383.0K | $228.0K | $448.0K | $703.0K | $37.0K | $157.0K | $1.5M | $444.4K | $325.5K | $892.6K | $334.7K | $52.2K | $2.0M | $285.9K | ||
| Investment Income Interest | $1.7M | $1.9M | $2.0M | $2.5M | $2.6M | $2.7M | $2.7M | $2.6M | $2.3M | $1.4M | $478.7K | $91.8K | $51.5K | $8.6K | $9.8K | $6.8K | $5.2K | |
| Depreciation And Amortization | $1.0M | $1.1M | $1.1M | $1.0M | $1.0M | $1.1M | $1.0M | $977.0K | $912.0K | $709.8K | $497.1K | $447.3K | $333.1K | $322.9K | $311.6K | $290.3K | $256.5K | |
| Net Book Value Of Consigned Equipment Sold | $11.0K | $17.0K | $32.8K | $1.6K | ||||||||||||||
| Additional Paid In Capital | $431.1M | $429.1M | $425.5M | $418.5M | $414.9M | $410.6M | $402.9M | $399.2M | $395.5M | $386.5M | $382.8M | $379.5M | $372.5M | $184.7M | ||||
| Capital Expenditures Incurred But Not Yet Paid | $16.0K | $631.0K | $43.2K | $21.2K | ||||||||||||||
| Interest And Other Expense | $116.0K | $289.0K | $13.2K | $742.3K | $263.2K | $164.7K | ||||||||||||
| Provision For Doubtful Accounts | $130.0K |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.